While hpv vaccinations are the most effective means of preventing hpv infections and related diseases, many people do not know how to choose the three types of vaccine, but the core difference is that the hpv sub-types covered are different, with a slight difference in the number of people being applied, without the need to blindly pursue the “higher the better” option。
The core coverage of the three types of vaccine is defined first: the two sub-types, which cover mainly hpv16 and 18, are the most responsible for cervical cancer and prevent approximately 70 per cent of cervical cancer; the four-value vaccine is increased by hpv6 and 11 on a double-price basis, and these two low-risk types are mainly causing acute wetting, so that the four-price vaccine will prevent not only cervical cancer but also acute wetting; and the nine-price vaccine is increased by hpv31, 33, 45, 52 and 58, which will prevent approximately 90 per cent of cervical cancer and acute wetting, with the widest coverage。
The three core groups are women aged 9-45, of whom who recommends that young women aged 9-14 be the primary target of hpv vaccination, which is the age group that does not start sex, has the best impact, and has two easier vaccinations. Men can also be vaccinated at 4 and 9 prices, mainly to prevent acute wetting and some anal and oral cancers, with the same applicable age of 9-45 years。
Option proposal: if the budget is limited and the focus is on the prevention of cervical cancer, the second price vaccine is fully adequate, the effect of the core cancer subtype is the same as the fourth price and the ninth price; if there is a concern about sharp wetting, the fourth price is available; if there is a sufficient budget, the ninth price is available for wider protection. It is important to note that vaccinations are complete (two or three shots) in order to achieve optimal protective effects, and that post-vaccination screening for cervical cancer is subject to regular screening。
Hpv infection
